{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:49:25Z","timestamp":1791179365805,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":2912,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1074\/jbc.m112.367532","type":"journal-article","created":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:13:22Z","timestamp":1344989602000},"page":"35484-35495","source":"Crossref","is-referenced-by-count":75,"title":["Tumor Microenvironment Macrophage Inhibitory Factor Directs the Accumulation of Interleukin-17-producing Tumor-infiltrating Lymphocytes and Predicts Favorable Survival in Nasopharyngeal Carcinoma Patients"],"prefix":"10.1016","volume":"287","author":[{"given":"Jiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yuan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ming","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Nan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M112.367532_bib1","first-page":"1355","article-title":"Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia","volume":"146","author":"Pathmanathan","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1074\/jbc.M112.367532_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5732\/cjc.010.10377","article-title":"The prevalence and prevention of nasopharyngeal carcinoma in China","volume":"30","author":"Cao","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"10.1074\/jbc.M112.367532_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5732\/cjc.009.10329","article-title":"Is nasopharyngeal cancer really a \u201cCantonese cancer\u201d?","volume":"29","author":"Wee","year":"2010","journal-title":"Chin. J. Cancer"},{"key":"10.1074\/jbc.M112.367532_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/scbi.1996.0023","article-title":"Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma. Viral gene expression, tumor cell phenotype, and the role of the lymphoid stroma","volume":"7","author":"Niedobitek","year":"1996","journal-title":"Semin. Cancer Biol."},{"key":"10.1074\/jbc.M112.367532_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/000348949710600416","article-title":"Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus","volume":"106","author":"Vasef","year":"1997","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1074\/jbc.M112.367532_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting. Integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1074\/jbc.M112.367532_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Cross-talk between cancer and immune cells. Role of STAT3 in the tumor microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1074\/jbc.M112.367532_bib8","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20090207","article-title":"IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway","volume":"206","author":"Wang","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1074\/jbc.M112.367532_bib9","doi-asserted-by":"crossref","first-page":"e18219","DOI":"10.1371\/journal.pone.0018219","article-title":"The accumulation and prognosis value of tumor-infiltrating IL-17-producing cells in esophageal squamous cell carcinoma","volume":"6","author":"Lv","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M112.367532_bib10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jhep.2008.12.033","article-title":"Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients","volume":"50","author":"Zhang","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1074\/jbc.M112.367532_bib11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"key":"10.1074\/jbc.M112.367532_bib12","doi-asserted-by":"crossref","first-page":"10170","DOI":"10.1158\/0008-5472.CAN-10-1943","article-title":"CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells","volume":"70","author":"D\u00fcrr","year":"2010","journal-title":"Cancer Res."},{"key":"10.1074\/jbc.M112.367532_bib13","doi-asserted-by":"crossref","first-page":"e19495","DOI":"10.1371\/journal.pone.0019495","article-title":"Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M112.367532_bib14","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.0902813","article-title":"Tumor microenvironments direct the recruitment and expansion of human Th17 cells","volume":"184","author":"Su","year":"2010","journal-title":"J. Immunol."},{"key":"10.1074\/jbc.M112.367532_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-4598-9-4","article-title":"Different subsets of tumor-infiltrating lymphocytes correlate with NPC progression in different ways","volume":"9","author":"Zhang","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1074\/jbc.M112.367532_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00002371-200307000-00005","article-title":"Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients","volume":"26","author":"Dudley","year":"2003","journal-title":"J. Immunother."},{"key":"10.1074\/jbc.M112.367532_bib17","unstructured":"Deleted in proof"},{"key":"10.1074\/jbc.M112.367532_bib18","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.intimp.2007.08.027","article-title":"Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells","volume":"7","author":"Kopf","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"10.1074\/jbc.M112.367532_bib19","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1128\/JVI.75.19.8957-8967.2001","article-title":"Antigenically distinct conformations of CXCR4","volume":"75","author":"Baribaud","year":"2001","journal-title":"J. Virol."},{"key":"10.1074\/jbc.M112.367532_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/jcp.47.5.453","article-title":"Clinical importance of p53 protein in gallbladder carcinoma and its precursor lesions","volume":"47","author":"Wee","year":"1994","journal-title":"J. Clin. Pathol."},{"key":"10.1074\/jbc.M112.367532_bib21","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/archinte.1990.00390230053007","article-title":"The association of selected cancers with service in the United States military in Vietnam. III. Hodgkin disease, nasal cancer, nasopharyngeal cancer, and primary liver cancer","volume":"150","year":"1990","journal-title":"Arch. Intern. Med."},{"key":"10.1074\/jbc.M112.367532_bib22","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/j.1349-7006.2010.01624.x","article-title":"Distribution of Th17 cells and FoxP3+ regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer","volume":"101","author":"Maruyama","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1074\/jbc.M112.367532_bib23","doi-asserted-by":"crossref","first-page":"15505","DOI":"10.1073\/pnas.0710686105","article-title":"Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer","volume":"105","author":"Miyahara","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M112.367532_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/CJI.0b013e318189f13c","article-title":"Tumor-derived TGF-\u03b2 mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer","volume":"32","author":"Moo-Young","year":"2009","journal-title":"J. Immunother."},{"key":"10.1074\/jbc.M112.367532_bib25","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00432-010-0833-8","article-title":"Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma","volume":"136","author":"Shen","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1074\/jbc.M112.367532_bib26","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/pmic.200800971","article-title":"Generation of high quality protein extracts from formalin-fixed, paraffin-embedded tissues","volume":"9","author":"Addis","year":"2009","journal-title":"Proteomics"},{"key":"10.1074\/jbc.M112.367532_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2567.2008.02879.x","article-title":"Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells","volume":"126","author":"Stojanovi\u0107","year":"2009","journal-title":"Immunology"},{"key":"10.1074\/jbc.M112.367532_bib28","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","article-title":"Cutting edge. An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity","volume":"179","author":"Harris","year":"2007","journal-title":"J. Immunol."},{"key":"10.1074\/jbc.M112.367532_bib29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"10.1074\/jbc.M112.367532_bib30","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4049\/jimmunol.0903006","article-title":"STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model","volume":"184","author":"Radojcic","year":"2010","journal-title":"J. Immunol."},{"key":"10.1074\/jbc.M112.367532_bib31","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4049\/jimmunol.0903421","article-title":"Macrophage migration inhibitory factor counter-regulates dexamethasone-mediated suppression of hypoxia-inducible factor-1\u03b1 function and differentially influences human CD4+ T cell proliferation under hypoxia","volume":"186","author":"Gaber","year":"2011","journal-title":"J. Immunol."},{"key":"10.1074\/jbc.M112.367532_bib32","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00109-008-0334-2","article-title":"Chemokine-like functions of MIF in atherosclerosis","volume":"86","author":"Schober","year":"2008","journal-title":"J. Mol. Med."},{"key":"10.1074\/jbc.M112.367532_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4049\/jimmunol.180.1.122","article-title":"Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells","volume":"180","author":"Lim","year":"2008","journal-title":"J. Immunol."},{"key":"10.1074\/jbc.M112.367532_bib34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1073\/pnas.0708594105","article-title":"Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis","volume":"105","author":"Swann","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M112.367532_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/mi.2008.84","article-title":"The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut","volume":"2","author":"Wang","year":"2009","journal-title":"Mucosal Immunol."},{"key":"10.1074\/jbc.M112.367532_bib36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbrc.2011.03.021","article-title":"IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma","volume":"407","author":"Liu","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1074\/jbc.M112.367532_bib37","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2009-12-255810","article-title":"Th17\/Treg ratio in human graft-versus-host disease","volume":"116","author":"Ratajczak","year":"2010","journal-title":"Blood"},{"key":"10.1074\/jbc.M112.367532_bib38","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, and th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res."},{"key":"10.1074\/jbc.M112.367532_bib39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-4598-9-4","article-title":"Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways","volume":"9","author":"Zhang","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1074\/jbc.M112.367532_bib40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri2742","article-title":"T(H)17 cells in tumor immunity and immunotherapy","volume":"10","author":"Zou","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1074\/jbc.M112.367532_bib41","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1073\/pnas.0808144106","article-title":"In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses","volume":"106","author":"Evans","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M112.367532_bib42","doi-asserted-by":"crossref","first-page":"12099","DOI":"10.1073\/pnas.0705268104","article-title":"IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells","volume":"104","author":"Kimura","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M112.367532_bib43","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1471-4159.2010.07136.x","article-title":"Synergistic activity of interleukin-17 and tumor necrosis factor-\u03b1 enhances oxidative stress-mediated oligodendrocyte apoptosis","volume":"116","author":"Paintlia","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1074\/jbc.M112.367532_bib44","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.4049\/jimmunol.1001728","article-title":"Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion","volume":"185","author":"Ye","year":"2010","journal-title":"J. Immunol."},{"key":"10.1074\/jbc.M112.367532_bib45","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.4049\/jimmunol.0803533","article-title":"Macrophage migration inhibitory factor homologs of anisakis simplex suppress Th2 response in allergic airway inflammation model via CD4+CD25+Foxp3+ T cell recruitment","volume":"182","author":"Park","year":"2009","journal-title":"J. Immunol."},{"key":"10.1074\/jbc.M112.367532_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/10408440903341696","article-title":"Epidemiological studies of formaldehyde exposure and risk of leukemia and nasopharyngeal cancer. A meta-analysis","volume":"40","author":"Bachand","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1074\/jbc.M112.367532_bib47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2172-11-50","article-title":"Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-\u03baB activation during Vibrio vulnificus infection","volume":"11","author":"Chuang","year":"2010","journal-title":"BMC Immunol."},{"key":"10.1074\/jbc.M112.367532_bib48","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/onc.2010.97","article-title":"Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer","volume":"29","author":"Chen","year":"2010","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M112.367532_bib49","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00432-009-0702-5","article-title":"Macrophage migration inhibitory factor expression in cervical cancer","volume":"136","author":"Krockenberger","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1074\/jbc.M112.367532_bib50","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1158\/1541-7786.MCR-10-0288","article-title":"Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors, and inhibits recruitment of cancer-associated fibroblasts","volume":"8","author":"Tarnowski","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1074\/jbc.M112.367532_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1479-5876-6-32","article-title":"Transcriptional patterns, biomarkers, and pathways characterizing nasopharyngeal carcinoma of Southern China","volume":"6","author":"Fang","year":"2008","journal-title":"J. Transl. Med."},{"key":"10.1074\/jbc.M112.367532_bib52","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jso.21728","article-title":"Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma","volume":"102","author":"Liao","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"10.1074\/jbc.M112.367532_bib53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.2003.tb03220.x","article-title":"Macrophage migration inhibitory factor (MIF). Its potential role in tumor growth and tumor-associated angiogenesis","volume":"995","author":"Nishihira","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1074\/jbc.M112.367532_bib54","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF03401765","article-title":"Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth","volume":"4","author":"Takahashi","year":"1998","journal-title":"Mol. Med."},{"key":"10.1074\/jbc.M112.367532_bib55","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1002\/cncr.24609","article-title":"Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer","volume":"115","author":"Xia","year":"2009","journal-title":"Cancer"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820626977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820626977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M112.367532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T06:49:36Z","timestamp":1641365376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820626977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":55,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0021925820626977"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m112.367532","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}